GlassScriptPhysician profile
Katherine A Getty
NPI 1902408891
$3,599.87
in general payments reported to CMS, 2019-2025
10 companies · $2,598 in 2025
The $2,598 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $249 · 2023: $160 · 2024: $153 · 2025: $2,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,614 · Travel and Lodging: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,614.26 |
| Travel and Lodging | $1,296.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $997.43 | 2025 | Stratafix |
| Medtronic, INC. | $778.68 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Abbott Laboratories | $589.88 | 2021-2025 | Proclaim |
| Boston Scientific Corporation | $548.43 | 2025 | Vercise, General - Dbs, Intracept |
| Si-Bone, INC. | $249.47 | 2021-2025 | |
| Ethicon US, LLC | $143.40 | 2025 | Stratafix, Ethicon, Monocryl |
| Haemonetics Corporation | $107.96 | 2023 | Teg5000 Hemostasis Analyzer |
| Depuy Synthes Sales INC. | $86.85 | 2024 | Conduit, X-Mesh, Xrl |
| Bioventus LLC | $65.89 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Lemaitre Vascular, INC. | $31.88 | 2023-2025 | Anastoclip Gc 8cm (Medium) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Getty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.